Pneumatic shock for chronic plantar fasciitis

NewsBot · Aug 12, 2009

Members do not see these Ads. Sign Up.
Intracorporeal pneumatic shock application for the treatment of chronic plantar fasciitis: a randomized, double blind prospective clinical trial.
Dogramaci Y, Kalaci A, Emir A, Yanat AN, Gökçe A.
Arch Orthop Trauma Surg. 2009 Aug 11. [Epub ahead of print]

OBJECTIVE: Plantar fasciitis (PF) is a common clinical condition that usually resolves with non-operative treatments. Extracorporeal shock wave therapy (ESWT) has been used in the treatment of chronic PF not responding to other conservative measures; however, ESWT devices are expensive and available for daily practice in only few centers (In developing countries). A pneumatic lithotripter is a cheap and readily available device which uses pneumatic shock application for the intracorporeal lithotripsy. The aim of this study was to investigate the clinical efficacy of intracorporeal pneumatic shock therapy (IPST) application for the treatment of chronic PF using a cheap and readily available pneumatic lithotripter.

METHODS: A randomized, double-blind, placebo-controlled study was conducted. A total of 50 patients with clinically and radiologically confirmed PF were randomly allocated to either an active- (treatment) (n = 25) or inactive (placebo) (n = 25) group. Under local anesthesia and posterior tibial nerve block, a rigid probe was directly introduced into the calcaneal spur under fluoroscopic control; a standard protocol of 1,000 shock was applied during a single session into the calcaneal spur. The main outcome measure was the patients' subjective assessment of pain by means of a Visual Analog Scale (VAS) and the Roles and Maudsley Score before the treatment and 6 months later.

RESULTS: At the 6 months, the rate of successful outcomes (excellent + good results) in the treatment group (92%) were significantly higher comparing to the control group (24%) (P < 0.001). Heel pain measured 6 months after using the VAS were 2.04 +/- 1.67 in treatment group and 7.16 +/- 1.57 in control group as compared to 8.92 +/- 1.22 and 9.12 +/- 1.23 before the commencement of the treatment. No complications attributable to the procedure such as rupture of the planter fascia, hematoma, or infection were observed during the study.

CONCLUSIONS: This pilot study showed that IPST is an effective and safe method of treatment of patients with chronic PF not responding to conservative measures. IPST application should be considered before surgical intervention when the extracorporeal shock devices are not available for daily practice. However, further evaluation of this novel treatment is necessary to understand the exact mechanism of action.
Click to expand...

Admin2 · Aug 12, 2009

Related Threads:
Other threads tagged with ESWT | Shockwave | Plantar fasciitis
Extracorporeal Shock Wave Therapy

Don ESWT · Aug 14, 2009

To all,
Are there any pictures of the machine used for this trial?
Don Scott

Craig Payne · Aug 14, 2009

I guess it may be similar to this:
http://www.curamedix.com/products.html

Don ESWT · Aug 15, 2009

Thanks Craig for the info. There are now several variations on the machines. I hope they are all working towards one standard of measurement when calibrating their machines, because as you know - oils ain't oils SOL (Castrol Ad from the 70's and 80's)

Don

NewsBot The Admin that posts the news.

Admin2 Administrator Staff Member

Don ESWT Active Member

Craig Payne Moderator

Don ESWT Active Member

Intermittent Pneumatic Compression Therapy and Diabetic Foot Ulcers

Concerned and shocked newbie

Use of extracorporeal shock wave therapy for children’s foot, ankle and leg concerns

Chattanooga RPW Mobile shockwave machine AS NEW

Shockwave for plantar fasciitis in cancer patients

Menisci Did Not Evolve to be Shock Absorbers

HealthWave/shockwave therapy Program FDA Cleared

Share This Page